» Articles » PMID: 18539142

MTORC2 Regulates PGE2-mediated Endothelial Cell Survival and Migration

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2008 Jun 10
PMID 18539142
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Prostaglandin E(2) (PGE(2)) promotes angiogenesis by in part inducing endothelial cell survival and migration. The present study examined the role of mTOR and its two complexes, mTORC1 and mTORC2, in PGE(2)-mediated endothelial cell responses. We used small interfering RNA (siRNA) to raptor or rictor to block mTORC1 or mTORC2, respectively. We observed that down-regulation of mTORC2 but not mTORC1 reduced baseline and PGE(2)-induced endothelial cell survival and migration. At the molecular level, we found that knockdown of mTORC2 inhibited PGE(2)-mediated Rac and Akt activation two important signaling intermediaries in endothelial cell migration and survival, respectively. In addition, inhibition of mTORC2 by prolonged exposure of endothelial cells to rapamycin also prevented PGE(2)-mediated endothelial cell survival and migration confirming the results obtained with the siRNA approach. Taken together these results show that mTORC2 but not mTORC1 is an important signaling intermediary in PGE(2)-mediated endothelial cell responses.

Citing Articles

Unveiling the Role of Mechanistic Target of Rapamycin Kinase (MTOR) Signaling in Cancer Progression and the Emergence of MTOR Inhibitors as Therapeutic Strategies.

Mehta D, Rajput K, Jain D, Bajaj A, Dasgupta U ACS Pharmacol Transl Sci. 2024; 7(12):3758-3779.

PMID: 39698262 PMC: 11650738. DOI: 10.1021/acsptsci.4c00530.


[Platelet-specific knockout inhibits platelet production and activation and reduces thrombosis in mice].

Long Q, Yang J, Liu A Nan Fang Yi Ke Da Xue Xue Bao. 2024; 44(8):1605-1611.

PMID: 39276057 PMC: 11378050. DOI: 10.12122/j.issn.1673-4254.2024.08.20.


Cancer Immunotherapy with "Vascular-Immune" Crosstalk as Entry Point: Associated Mechanisms, Therapeutic Drugs and Nano-Delivery Systems.

Jiang Z, Fang Z, Hong D, Wang X Int J Nanomedicine. 2024; 19:7383-7398.

PMID: 39050878 PMC: 11268745. DOI: 10.2147/IJN.S467222.


mTOR signalling pathway in stem cell bioactivities and angiogenesis potential.

Lotfimehr H, Mardi N, Narimani S, Nasrabadi H, Karimipour M, Sokullu E Cell Prolif. 2023; 56(12):e13499.

PMID: 37156724 PMC: 10693190. DOI: 10.1111/cpr.13499.


mTORC2 interactome and localization determine aggressiveness of high-grade glioma cells through association with gelsolin.

Chantaravisoot N, Wongkongkathep P, Kalpongnukul N, Pacharakullanon N, Kaewsapsak P, Ariyachet C Sci Rep. 2023; 13(1):7037.

PMID: 37120454 PMC: 10148843. DOI: 10.1038/s41598-023-33872-y.